
The most widespread variant so far in the U.S. is B.1.1.7, first discovered in the U.K. . . . → Read More: Infographic – States Reporting SARS-CoV-2 Variants
|
|||||
![]() The most widespread variant so far in the U.S. is B.1.1.7, first discovered in the U.K. . . . → Read More: Infographic – States Reporting SARS-CoV-2 Variants ![]() A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020. . . . → Read More: 20 Precision Meds Approved by FDA in 2020 ![]() An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies. . . . → Read More: AI Designs Better Gene Therapy Delivery Viruses ![]() Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine ![]() Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process ![]() The Food and Drug Administration granted an emergency authorization for a combination of two synthetic antibodies to treat non-hospitalized Covid-19 infections. . . . → Read More: FDA Clears Covid-19 Dual-Antibody Therapy ![]() A study shows heart rate data captured by an Apple watch can provide an early warning of impending Covid-19 infections, even before a positive test. . . . → Read More: Smartwatch Shown to Offer Early Covid-19 Warning ![]() A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines ![]() A new study shows an Apple watch can capture data on tremors experienced by people with Parkinson’s disease to help provide more precise care. . . . → Read More: Apple Watch Helps Personalize Parkinson’s Care ![]() A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO. . . . → Read More: Engineered Cell Therapy Company Issues $588M IPO |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |